Governance Iqvia Holdings Inc.

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2026-01-20 pm EST			5-day change	1st Jan Change
233.69 ^USD	-1.68%		-3.26%	+3.67%

Jan. 16	Promising launch for Wegovy pill: Novo Nordisk shares surge in the US
Jan. 16	Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly	RE

Executive Committee: Iqvia Holdings Inc.

Manager

Positions heldSince

Ari Bousbib

65 year

Chief Executive Officer	2016-10-02
President	2016-10-02

Keriann Cherofsky

42 year

Comptroller/Controller/Auditor

2022-07-31

Jeffrey Spaeder

Chief Tech/Sci/R&D Officer

Ronald Bruehlman

65 year

Director of Finance/CFO

2020-07-31

James Berkshire

53 year

Chief Operating Officer	2017-06-30
Chief Tech/Sci/R&D Officer	-

Eric Sherbet

61 year

General Counsel	2018-02-28
Corporate Secretary	-

W. Staub

63 year

Chief Tech/Sci/R&D Officer

2023-09-24

Trudy Stein

Human Resources Officer

2016-10-02

Karl Guenault

Chief Tech/Sci/R&D Officer

2017-10-31

Composition of the Board of Directors: Iqvia Holdings Inc.

Director

CommitteesSince

Ari Bousbib

65 year

Audit Committee	2009-06-14
Finance Committee Chair	2013-04-10

Todd Sisitsky

54 year

Compensation Committee	2018-03-31
Governance Committee	2018-03-31
Nominating Committee	2018-03-31
Governance Committee Chair
Nominating Committee Chair
Executive Committee

John Danhakl

69 year

Compensation Committee Chair	1994-12-31
Nominating Committee Chair	1994-12-31
Compensation Committee
Governance Committee	2015-05-31
Nominating Committee	2015-05-31

Carol Burt

68 year

Audit Committee	2019-09-30
Governance Committee	2013-10-31
Nominating Committee Chair	2013-10-31
Audit Committee Chair
Compensation Committee Chair

Colleen Goggins

70 year

Nominating Committee
Audit Committee	2017-07-26
Governance Committee Chair	2017-07-26
Nominating Committee Chair	2017-07-26

Sheila Stamps

68 year

Compensation Committee	2021-12-14
Governance Committee	2021-12-14
Nominating Committee	2021-12-14
Audit Committee	2022-01-25

John Leonard

68 year

Audit Committee	2016-09-30
Governance Committee	2016-09-30
Nominating Committee	2016-09-30

Leslie Morris

55 year

Governance Committee	2022-01-23
Nominating Committee	2022-01-23

William Kaelin

68 year

Governance Committee

John Connaughton

60 year

Compensation Committee

Jim Fasano

56 year

Audit Committee Chair

2016-10-02

Latest Appointments: Iqvia Holdings Inc.

Jan. 08	Syneos Health, Inc. Appoints Simon Bartle as Chief Human Resources Officer, Effective January 8, 2026	CI
Dec. 17	Bavarian Nordic as Appoints Anne Louise Eberhard as New Chair of the Board of Directors	CI
Dec. 08	Halozyme Therapeutics, Inc. Announces Election of Jim Lang to Board of Directors, Effective December 4, 2025	CI
Nov. 05	Dr. William G. Kaelin Jr. joins IQVIA board of directors	RE
Nov. 05	IQVIA Appoints William G. Kaelin Jr. to its board of directors, Effective November 5, 2025	CI
25-09-02	Iqvia announces CFO transition in early 2026	RE
25-09-02	IQVIA Holdings Inc. Announces Executive Vice President Changes, Effective February 28, 2026	CI

More news

Former Officers and Directors: Iqvia Holdings Inc.

Insider

Positions held

SinceUntil

Kevin Knightly

Corporate Officer/Principal

2024-05-14

Costa Panagos

Chief Tech/Sci/R&D Officer

2023-09-24

Ronald Rittenmeyer

Director/Board Member	2016-10-02	2022-10-01
Independent Dir/Board Member	2016-10-02	2022-10-01

Tor Constantino

Public Communications Contact

2013-07-31

2022-07-31

Emmanuel N. Korakis

Comptroller/Controller/Auditor	2018-10-31	2022-07-30
Treasurer	-	2022-07-30

Jean Roberson

Director of Finance/CFO

2020-06-30

2022-05-31

Drayton Virkler

Corporate Officer/Principal

2011-09-30

2021-08-31

Nick Childs

Investor Relations Contact	2021-03-31	-
Public Communications Contact	2021-03-31	-
Treasurer	-	-

Jennifer Halchak

Investor Relations Contact

2018-12-31

2020-12-31

Michael McDonnell

Director of Finance/CFO

2015-11-30

2020-07-30

Michael J. Evanisko

Director/Board Member	2010-04-30	2020-04-05
Independent Dir/Board Member	2010-04-30	2020-04-05

Jonathan Coslet

Director/Board Member	2002-12-31	2019-12-31
Independent Dir/Board Member	2002-12-31	2019-12-31

Manav Dagar

Private Equity Investor

2018-12-31

2019-10-30

Donna Kralowetz

Director of Finance/CFO

2017-04-30

2019-05-30

Jack Greenberg

Director/Board Member	2003-12-31	2019-03-31
Independent Dir/Board Member	2003-12-31	2019-03-31

Charles Edward Williams

Comptroller/Controller/Auditor

2018-10-31

James Hanson

Corporate Officer/Principal

2017-10-31

2018-05-31

Benjamin Hughes

Corporate Officer/Principal

2013-12-31

2018-02-28

Richie Etwaru

Corporate Officer/Principal

2015-03-31

2018-02-28

James Erlinger

General Counsel	2016-10-02	2018-02-27
Corporate Secretary	2016-10-02	2018-02-27

Terry Murdock

Corporate Officer/Principal

2014-08-31

2017-06-30

Michael Stibilj

Corporate Officer/Principal

2014-12-31

2017-05-31

Marla Kessler

Public Communications Contact	2016-09-30	-
Sales & Marketing	2016-09-30	-

Kevin Gordon

Chief Operating Officer

2015-09-30

2016-09-30

Tal Rosenberg

Corporate Officer/Principal

2016-09-30

Darcie Peck

Investor Relations Contact	2002-04-30	2009-10-31
Corporate Officer/Principal	2009-10-31	2016-01-31

Lisa van Capelle

Human Resources Officer

2003-12-31

2015-12-31

Melissa Beelen

Corporate Officer/Principal

2010-07-31

2015-10-31

Fred Cohen

Director/Board Member

2006-12-31

2015-10-31

Michael Ackermann

Private Equity Investor

2009-04-30

2013-10-31

Christopher Katz

Consultant / Advisor

2010-05-31

2012-07-30

Thomas Pike

Director/Board Member	2011-12-31	-
Corporate Officer/Principal	2011-12-31	-

Daniel Barton

Corporate Officer/Principal

2011-10-31

Qiao Ling Lu

Corporate Officer/Principal

2006-03-31

2010-07-31

John Hernandez

Corporate Officer/Principal

1999-12-31

2000-12-31

David Hood

Corporate Officer/Principal

1992-12-31

1999-12-31

Gary Koch

Founder

1981-12-31

Edward Spaniel

General Counsel

Patrick Daly

Corporate Officer/Principal

Caroline Ruiz

Corporate Officer/Principal

Paul Kirchgraber

Chief Tech/Sci/R&D Officer

Melissa Schwarting

Public Communications Contact

Natalia Balko Kotchie

Corporate Officer/Principal

Christopher Gordon

Director/Board Member

Andrei Stoica

Corporate Officer/Principal

Margaret Keegan

Chief Tech/Sci/R&D Officer

Phil Bridges

Public Communications Contact

Andrew Markwick

Investor Relations Contact	-	-
Treasurer	-	-

Anand Kumaresh Tharmaratnam

President

Ibraheem Mahmood

Corporate Officer/Principal

Jon Resnick

Corporate Officer/Principal

Cynthia L. Verst

Corporate Officer/Principal

Bhavik Patel

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	16
Female	6

Of which Executive Committee

Male	7
Female	2

Of which Directors

Male	7
Female	4

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (55.4%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (4.7%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (47.8%), Europe and Africa (31.9%) and Asia/Pacific (20.3%).

Employees

91,000

Sector

Biotechnology & Medical Research

Calendar

Feb. 17 - Q4 2025 Earnings Release (Projected)

More about the company